Get the Stockscreener App
4.17
0.24%
0.010
After Hours:
4.17
Evolent Health Inc stock is traded at $4.17, with a volume of 1.94M.
It is up +0.24% in the last 24 hours and up +5.84% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$4.16
Open:
$4.17
24h Volume:
1.94M
Relative Volume:
0.56
Market Cap:
$465.38M
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-4.4362
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
+7.20%
1M Performance:
+5.84%
6M Performance:
-63.06%
1Y Performance:
-66.90%
1-Day Range:
$4.08
$4.25
1-Week Range:
$3.86
$4.26
52-Week Range:
$3.495
$12.98
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.17 | 464.26M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Does Evolent Health Inc. stock trade at a discount to peersQuarterly Trade Review & Daily Profit Maximizing Trade Tips - ulpravda.ru
How Evolent Health Inc. stock reacts to inflationary pressures2025 Volatility Report & Step-by-Step Swing Trade Plans - ulpravda.ru
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Aug Wrap: How Evolent Health Inc. stock reacts to bond yieldsTrend Reversal & Long-Term Growth Portfolio Plans - ulpravda.ru
Quarterly Earnings: How Evolent Health Inc stock reacts to job market dataQuarterly Market Summary & Free Safe Entry Trade Signal Reports - moha.gov.vn
Entry Recap: How Evolent Health Inc. stock reacts to job market dataMarket Volume Report & Technical Pattern Recognition Alerts - ulpravda.ru
Setup Watch: How Evolent Health Inc. stock reacts to inflationary pressures2025 Investor Takeaways & Fast Gain Swing Alerts - ulpravda.ru
How sustainable is Evolent Health Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - ulpravda.ru
How Evolent Health Inc. stock reacts to bond yieldsCPI Data & Fast Entry Momentum Trade Alerts - ulpravda.ru
How Evolent Health Inc. stock reacts to job market dataPortfolio Growth Summary & High Conviction Trade Alerts - ulpravda.ru
Insider Stock Buying Reaches US$1.38m On Evolent Health - Yahoo Finance
Is the options market predicting a spike in Evolent Health stock? - MSN
Evolent Health (EVH) Analyst Maintains Rating, Lowers Price Targ - GuruFocus
Evolent Health, Inc. (EVH) Stock Analysis: Can a 155% Upside Propel This Healthcare Innovator? - DirectorsTalk Interviews
Citizens lowers Evolent Health stock price target on ACA membership concerns - Investing.com Canada
Evolent Health (EVH) sells ACO unit, strengthens balance sheet - MSN
Evolent reports inducement award - Medical Buyer
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 - The Malaysian Reserve
Evolent reports inducement award under NYSE listing rule 303A.08 - MarketScreener
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08 – Company Announcement - Financial Times
The Truth About Evolent Health Inc (EVH): Underdog Stock or Next Big Health Tech Flex? - AD HOC NEWS
Evolent Health, Inc. (EVH) Stock Analysis: Evaluating A Promising 150% Potential Upside - DirectorsTalk Interviews
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - Quantisnow
Is the Options Market Predicting a Spike in Evolent Health Stock? - Zacks Investment Research
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet - Finviz
11 Best Healthcare AI Stocks to Buy Now - Insider Monkey
Would You Still Hold Evolent Health Stock If It Fell 30%? - Trefis
Evolent Health (EVH) downgraded by Canaccord amid increased near-term uncertainty and ambiguity in Medicare/Medicaid membership - MSN
Energy Moves: Why Evolent Health Inc stock is trending among retail tradersPortfolio Update Summary & Trade Opportunity Analysis Reports - moha.gov.vn
How Evolent Health Inc Class stock compares with tech leaders2025 Short Interest & Daily Entry Point Alerts - Улправда
Why Evolent Health Inc. stock is trending among retail tradersWeekly Market Outlook & Free Community Consensus Stock Picks - DonanımHaber
How Evolent Health Inc Class stock reacts to Fed tighteningJuly 2025 Closing Moves & Trade Opportunity Analysis - DonanımHaber
Can Evolent Health Inc Class stock surprise with quarterly resultsJuly 2025 Levels & Daily Entry Point Trade Alerts - DonanımHaber
Is Evolent Health Inc. stock a dividend growth opportunityJuly 2025 Reactions & Scalable Portfolio Growth Methods - Улправда
EVH (Evolent Health) Debt-to-Asset : 0.44 (As of Sep. 2025) - GuruFocus
Evolent Health (EVH) Downgraded by Canaccord Amid Increased Near-Term Uncertainty and Ambiguity in Medicare/Medicaid Membership - Insider Monkey
Is Evolent Health Inc 9EH a good long term investmentStock Market Trends & These 3 Stocks Could Change Your Portfolio - earlytimes.in
20 Stocks That Will Double in 2026 - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Evolent Health (EVH) and AbSci (ABSI) - The Globe and Mail
Evolent Health (EVH) director files insider report showing no share holdings - Stock Titan
Evolent Health Reports Strong Q3 2025 Results - MSN
3 Healthcare Stocks We Think Twice About - Yahoo Finance
Free cash flow per share of Evolent Health Inc Class A – BER:9EH - TradingView — Track All Markets
How the Narrative Surrounding Evolent Health Is Shifting After New Contracts and Softer Earnings Outlook - Yahoo Finance
(EVH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Evolent Health Completes Stock Purchase Agreement - TipRanks
Privia Health completes acquisition of ACO business from Evolent Health By Investing.com - Investing.com South Africa
Privia Health completes acquisition of ACO business from Evolent Health - Investing.com
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.07%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):